Company: INMB
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0001213900-25-073077
Chunk: 57

Company: Inmune Bio, Inc.
Filing Date: 2025-08-07
Form: 10-Q
Item: Part I, Item 1
Chunk 57
---
ComprehensiveIncomeMember

    2024-04-01
    2024-06-30

    0001711754
    
      us-gaap:RetainedEarningsMember

    2024-04-01
    2024-06-30

    0001711754
    
      us-gaap:CommonStockMember

    2024-06-30

    0001711754
    
      us-gaap:AdditionalPaidInCapitalMember

    2024-06-30

    0001711754
    
      us-gaap:AccumulatedOtherComprehensiveIncomeMember

    2024-06-30

    0001711754
    
      us-gaap:RetainedEarningsMember

    2024-06-30

    0001711754

    2024-06-30

    0001711754
    
      us-gaap:EmployeeStockOptionMember

    2025-01-01
    2025-06-30

    0001711754
    
      us-gaap:EmployeeStockOptionMember

    2024-01-01
    2024-06-30

    0001711754
    
      us-gaap:WarrantMember

    2025-01-01
    2025-06-30

    0001711754
    
      us-gaap:WarrantMember

    2024-01-01
    2024-06-30

    0001711754
    
      country:AU

    2025-01-01
    2025-06-30

    0001711754
    
      country:AU

    2024-01-01
    2024-12-31

    0001711754
    
      inmb:GreatOrmondStreetHospitalMember

    2025-06-30

    0001711754
    
      inmb:GreatOrmondStreetHospitalMember

    2024-12-31

    0001711754
    
      inmb:MilestonePaymentPhaseOneInitiationMember
      inmb:INKmuneLicenseAgreementMember

    2025-01-01
    2025-06-30

    0001711754
    
      inmb:MilestonePaymentPhaseTwoInitiationMember